Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumor differentiation

Radiotherapy and Oncology

Volumn 43, Issue 1, 1997, Pages 47-51

  Hansen, Olfred ^a,b   Overgaard, Jens ^a   Hansen, Hanne Sand ^c   Overgaard, Marie ^d   Høyer, Morten ^a,d   Jørgensen, Karsten E ^b   Bastholt, Lars ^b   Berthelsen, Anne ^e  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c FINSEN LABORATORY   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

differentiation; head and neck carcinoma; local control; overall treatment time; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; TIME FACTORS;

EID: 0030996326     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01904-X     Document Type: Article

References (24)

1. Begg, A.C., Hofland, I., Van Glabekke, M., Bartelink, H. and Horiot, J.C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results from the EORTC cooperative trial 22851. Semin. Radiat. Oncol. 2: 22-25, 1992.
2. Bennet, M.H., Wilson, G.D., Dische, S. et al. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 65: 870-878, 1992.
3. Bentzen, S.M., Ruifrok, A.C.C. and Thames, H.D. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy. Radiother. Oncol. 38: 89-101, 1996.
4. Bourhis, J., Wilson, G., Wibault, P. et al. In vivo measurement of the potential doubling time by flow cytometry in oropharyngeal cancer treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26: 793-799, 1993.
5. Bristow, R.G., Benchimol, S., Hill, R.P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother. Oncol. 40: 197-223, 1996.
6. Broders, A.C. Squamous cell epithelioma of the lip. J. Am. Med. Assoc. 74: 656-664, 1920.
7. Carl, J., Andersen, L.J., Pedersen, M. and Greisen, O. Prognostic factors of local control after radiotherapy in T1 glottic and supreglottic carcinoma of the larynx. Radiother. Oncol. 39: 229-233, 1996.
8. Corvò, R., Giaretti, G., Sanguineti, G. et al. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol. 13: 1843-1850, 1995.
9. Dische, S., Saunders, M.I., Bennet, M.H., Wilson, G.D. and McNally, N.J. Cell proliferation and differentiation in squamous cancer. Radiother. Oncol. 15: 19-23, 1989.
10. Dörr, W. and Kummermehr, J. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother. Oncol. 17: 249-259, 1990.
11. Lochrin, C.A., Wilson, G.D., McNally, N.J., Dische, S. and Saunders, M.I. Tumor cell kinetics, local tumor control, and accelerated radiotherapy: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 24: 87-91, 1992.
12. Nishimura, Y., Nagata, Y., Okajima, K. et al. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother. Oncol. 40: 225-232, 1996.
13. Nylander, K., Anneroth, G., Gustafsson, H., Roos, G., Stenling, R. and Zackariasson, B. Cell kinetics of head and neck squamous cell carcinoma. Acta Oncol. 33: 23-28, 1994.
14. Overgaard, J., Hansen, H.S., Andersen, A.P. et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx of pharynx: report from the DAHANCA 2 study. Int. J. Radiat. Oncol. Biol. Phys. 16: 1065-1068, 1989.
15. Overgaard, J., Hansen, H.S., Jørgensen, K. and Hjelm-Hansen, M. Primary radiotherapy of larynx and pharynx carcinoma: an analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys. 12: 515-521, 1986.
16. Overgaard, J., Hansen, H.S., Overgaard, M. et al. The Danish head and neck cancer study group (DAHANCA) randomized trials with hypoxic radiosensitizers in carcinoma of the larynx and pharynx. In: Radiation Research: A Twentieth Century Perspective. Volume II: Congress Proceedings, pp. 573-577. Editors: W.C. Dewey, M. Edington, R.J.M. Fry, E.J. Hall, G.F. Whitmore. Academic Press, New York, 1991.
17. Overgaard, J., Hjelm-Hansen, M., Johansen, L.V. and Andersen, A.P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27: 147-152, 1988.
18. Rudoltz, M.S., Benammar, A. and Mohiuddin, M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int. J. Radiat. Oncol. Biol. Phys. 26: 767-772, 1993.
19. Saunders, M.I., Dische, S., Fowler, J.F. et al. Radiotherapy employing three fractions on each of twelve consecutive days. Acta Oncol. 27: 163-167, 1988.
20. Terhaard, C.H.J., Snippe, K., Ravasz, L.A., Van Der Tweel, I. and Hordijk, G.J. Radiotherapy in T1 laryngeal cancer: Prognostic factors for locoregional control and survival, uni-and multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 21: 1179-1186, 1991.
21. Van den Bogaert, W., Van der Schueren, E., Horiot, J.-C. et al. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother. Oncol. 35: 100-106, 1995.
22. Van den Bogaert, W., Van der Leest, A., Rijnders, A., Delaere, P., Thames, H., and Van der Schueren, E. Does tumor control ,decrease by prolonging overall treatment time or interupting treatment in laryngeal cancer. Radiother. Oncol. 36: 177-182, 1995.
23. Wilson, G.D., Dische, S. and Saunders, M.I. Studies with bromdeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 36: 1000-1001, 1995.
24. Withers, H.R., Taylor, J.M.G. and Maciejewski, B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27: 131-146, 1988.